Production of biofuel and protein from a raw material

Details for Australian Patent Application No. 2008207207 (hide)

Owner UpFront Chromatography A/S

Inventors Lihme, Allan Otto Fog

Agent FB Rice

Pub. Number AU-B-2008207207

PCT Pub. Number WO2008/086811

Priority 60/884,948 15.01.07 US

Filing date 15 January 2008

Wipo publication date 24 July 2008

Acceptance publication date 18 October 2012

International Classifications

B01D 15/02 Separating processes involving the treatment of liquids with solid sorbents - with moving adsorbents

A23J 1/00 Obtaining protein compositions for foodstuffs

B01D 15/00 Separating processes involving the treatment of liquids with solid sorbents

C07K 1/22 General processes for the preparation of peptides

C10L 1/02 Liquid carbonaceous fuels

C10L 1/18 Liquid carbonaceous fuels

C12P 7/10 Preparation of oxygen-containing organic compounds

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/086811 Priority application(s): WO2008/086811

13 August 2009 Amendment Made

  The nature of the amendment is: Delete the inventor Lihme, Allan Otto Fog

27 August 2009 Amendment Made

  The nature of the amendment is: Delete the co-applicant Allan Otto Fog Lihme

18 November 2010 Alteration of Name

  The name of the applicant has been altered to UpFront Chromatography A/S

18 October 2012 Application Accepted

  Published as AU-B-2008207207

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207241-Media supply plate for a fuel cell stack

2008207200-Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse